Background illustration for clinical trials search

Paid Clinical Trials West Palm Beach

Discover 1,042 paid clinical trials in West Palm Beach, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,042

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

for

Metabolic Dysfunction Associated Steatohepatitis

Location: Pembroke Pines FL, Miami Lakes FL, Hialeah FL, Miami FL,

Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06632457

Phase 3, Recruiting

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

for

Metabolic Dysfunction Associated Steatohepatitis (MASH),

Location: Pembroke Pines FL, Miami Lakes FL, Hialeah FL, Miami FL,

Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06632444

Phase 3, Recruiting

Study of SIR2501 in Solid Tumor Patients Receiving Paclitaxel

for

Chemotherapy-induced Peripheral Neuropathy

Location: Hollywood FL, Baltimore MD, East Brunswick NJ

Sponsor: Sironax USA, Inc.

Sex: All

Age: 18+

Code: NCT07765446

Phase 2, Recruiting

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

for

Multiple Myeloma

Location: Pembroke Pines FL, Wilson NC, Chapel Hill NC,

Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT05714839

Phase 1, Phase 2, Recruiting

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

for

Multiple Myeloma, Newly Diagnosed Multiple Myeloma

Location: Pembroke Pines FL, Englewood FL, Lady Lake FL,

Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06679101

Phase 3, Recruiting

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients

for

Squamous Cell Carcinoma, Alpha Radiation, Immunocompromised,

Location: Hollywood FL, Atlanta GA, Cooperstown NY, Gilbert AZ,

Sponsor: Alpha Tau Medical LTD.

Sex: All

Age: 18+

Code: NCT06615635

Recruiting

Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR

for

Aortic Valve Stenosis, Aortic Valve Regurgitation,

Location: Hollywood FL, Cincinnati OH, Royal Oak MI, Rochester MN,

Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

Sex: All

Age: 18+

Code: NCT05459233

Recruiting

Pharmacogenomic Testing Of the Elderly To Reduce Morbidity

for

Genetics of Drug Metabolism

Location: Pembroke Pines FL, Tallahassee FL, Nashville TN,

Sponsor: General Genetics Corporation

Sex: All

Age: 18+

Code: NCT02095769

Recruiting

Study of ALTO-101 in Patients With Schizophrenia

for

Schizophrenia, Cognitive Impairment

Location: Hollywood FL, Tampa FL, Snellville GA, Gaithersburg MD,

Sponsor: Alto Neuroscience

Sex: All

Age: 21 - 55

Code: NCT06502964

Phase 2, Recruiting

NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease

for

Graves Disease

Location: Hollywood FL, Miami FL, Wesley Chapel FL,

Sponsor: Merida Biosciences

Sex: All

Age: 18 - 65

Code: NCT07305818

Phase 1, Recruiting

A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

for

Primary Biliary Cholangitis (PBC)

Location: Pembroke Pines FL, Miami FL, Tampa FL, Charleston SC,

Sponsor: Ipsen

Sex: All

Age: 18+

Code: NCT06016842

Phase 3, Recruiting

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

for

Sickle Cell Disease Vaso-occlusive Crisis

Location: Hollywood FL, Fort Myers FL, Atlanta GA, Greenville NC,

Sponsor: CSL Behring

Sex: All

Age: 12+

Code: NCT06699849

Phase 2, Recruiting

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

for

Sickle Cell Disease

Location: Hollywood FL, Atlanta GA, Flowood MS, Richmond VA,

Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT07224360

Phase 2, Recruiting

Tissue Repair Gel in Venous Leg Ulcers (US)

for

Venous Leg Ulcer, Venous Ulcer, Venous Stasis Ulcer,

Location: Pembrook Pines FL, Miami FL, Jacksonville FL,

Sponsor: TR Therapeutics

Sex: All

Age: 18+

Code: NCT06707090

Phase 3, Recruiting

Continuous Monitoring and Control of Hypoglycemia

for

Diabetes

Location: Pembroke Pines FL, Tampa FL, Oklahoma City OK,

Sponsor: DexCom, Inc.

Sex: All

Age: 2+

Code: NCT03340831

Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

for

Metastatic Castration-resistant Prostate Cancer (mCRPC),

Location: Pembroke Pines FL, Miami Beach FL, Charleston SC,

Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136650

Phase 3, Recruiting

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

for

Myelodysplastic Syndrome

Location: Pembroke Pines FL, Miami FL, Gainesville FL, Albany GA,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06577441

Phase 2, Recruiting

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

for

Acute Myeloid Leukemia

Location: Pembroke Pines FL, Miami FL, Augusta GA, Greenville SC,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06672146

Phase 2, Recruiting

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

for

Core Binding Factor Acute Myeloid Leukemia

Location: Pembroke Pines FL, Greenville SC, Seneca SC, Easley SC,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT06917911

Phase 2, Recruiting

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

for

Acute Myeloid Leukemia,

Location: Pembroke Pines FL, Miami FL, Jacksonville FL, Albany GA,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554406

Phase 2, Recruiting

Paid Clinical Trials West Palm Beach

Filter results

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Study of SIR2501 in Solid Tumor Patients Receiving Paclitaxel

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

Interested in new trials?

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients

Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR

Pharmacogenomic Testing Of the Elderly To Reduce Morbidity

Study of ALTO-101 in Patients With Schizophrenia

NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease

A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

Tissue Repair Gel in Venous Leg Ulcers (US)

Continuous Monitoring and Control of Hypoglycemia

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)